MX350277B - Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso. - Google Patents

Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso.

Info

Publication number
MX350277B
MX350277B MX2013009993A MX2013009993A MX350277B MX 350277 B MX350277 B MX 350277B MX 2013009993 A MX2013009993 A MX 2013009993A MX 2013009993 A MX2013009993 A MX 2013009993A MX 350277 B MX350277 B MX 350277B
Authority
MX
Mexico
Prior art keywords
methods
deficient
sporulation
efficient
cost
Prior art date
Application number
MX2013009993A
Other languages
English (en)
Other versions
MX2013009993A (es
Inventor
Yiwei Jiang
Original Assignee
Mygalaxy Ltd Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mygalaxy Ltd Company filed Critical Mygalaxy Ltd Company
Publication of MX2013009993A publication Critical patent/MX2013009993A/es
Publication of MX350277B publication Critical patent/MX350277B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)

Abstract

La presente invención se refiere a nuevas cepas y métodos para su uso. Particularmente, alimentos y otros productos o tratamientos orales que contengan cepas Brevibacillus deficientes de esporulación cuando se administra a un sujeto pueden inhibir o reducir el número de patógenos en el sujeto y mejorar la salud del mismo.
MX2013009993A 2011-03-01 2012-02-28 Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso. MX350277B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161447703P 2011-03-01 2011-03-01
US13/406,202 US8673290B2 (en) 2011-03-01 2012-02-27 Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof
PCT/US2012/026999 WO2012118845A1 (en) 2011-03-01 2012-02-28 Sporulation-deficient b. texasporus cells and methods for efficient and cost-effective inactivation and use thereof

Publications (2)

Publication Number Publication Date
MX2013009993A MX2013009993A (es) 2013-12-06
MX350277B true MX350277B (es) 2017-08-30

Family

ID=46753436

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009993A MX350277B (es) 2011-03-01 2012-02-28 Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso.

Country Status (15)

Country Link
US (3) US8673290B2 (es)
EP (2) EP3002340A1 (es)
JP (1) JP5970483B2 (es)
KR (1) KR20140015356A (es)
CN (2) CN103732734B (es)
AR (1) AR088715A1 (es)
AU (1) AU2012223481B2 (es)
BR (1) BR112013021892B1 (es)
CA (1) CA2828541C (es)
CL (1) CL2013002370A1 (es)
CO (1) CO6751281A2 (es)
MX (1) MX350277B (es)
RU (1) RU2013137673A (es)
WO (1) WO2012118845A1 (es)
ZA (1) ZA201306276B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6345186B2 (ja) * 2012-12-17 2018-06-20 エムワイギャラクシー リミテッド カンパニー 肥満および関連疾患の治療剤としてのｂｔリポペプチドの使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302544A (en) 1979-10-15 1981-11-24 University Of Rochester Asporogenous mutant of B. subtilis for use as host component of HV1 system
US4450235A (en) 1982-04-21 1984-05-22 Cpc International Inc. Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system
US4450236A (en) 1982-04-21 1984-05-22 Cpc International Inc. Asporogenic mutant of Bacillus subtilis useful as a host in a host-vector system
US4465773A (en) 1982-04-21 1984-08-14 Cpc International Inc. Amylase-negative, asporogenous mutant of Bacillus subtilis useful as a host in a host-vector system
US5480641A (en) 1990-06-15 1996-01-02 Biogaia Ab Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract
IT1244477B (it) * 1990-12-21 1994-07-15 Eniricerche Spa Ceppo asporigeno di bacillus subtilis e suo impiego come ospite per la preparazione di prodotti eterologhi
WO2004095941A1 (en) 2003-04-28 2004-11-11 Alpharma, Inc. Method for formulation of microbial feed additives with feed
US7655452B1 (en) 2003-11-11 2010-02-02 Higeta Shoyu Co., Ltd. Brevibacillus choshinensis and process for prodcuing protein wtih use of the microbe as host
CA2554634A1 (en) * 2004-01-30 2005-08-18 The Texas A & M University System Compositions, methods and uses for a novel family of peptides
JP2010220539A (ja) * 2009-03-24 2010-10-07 Tosoh Corp 胞子形成能が欠損した細菌、及びそれを用いたタンパク質製造方法

Also Published As

Publication number Publication date
MX2013009993A (es) 2013-12-06
CN105567587A (zh) 2016-05-11
US8673290B2 (en) 2014-03-18
CN103732734A (zh) 2014-04-16
CL2013002370A1 (es) 2014-04-04
CN103732734B (zh) 2016-01-20
AU2012223481A1 (en) 2013-08-29
US20140162343A1 (en) 2014-06-12
US20120225037A1 (en) 2012-09-06
AR088715A1 (es) 2014-07-02
WO2012118845A1 (en) 2012-09-07
RU2013137673A (ru) 2015-04-10
JP5970483B2 (ja) 2016-08-17
CA2828541C (en) 2020-04-21
US20140199753A1 (en) 2014-07-17
AU2012223481B2 (en) 2016-06-30
CO6751281A2 (es) 2013-09-16
BR112013021892A2 (pt) 2016-09-06
EP3002340A1 (en) 2016-04-06
CA2828541A1 (en) 2012-09-07
EP2681338A1 (en) 2014-01-08
JP2014512807A (ja) 2014-05-29
ZA201306276B (en) 2016-07-27
EP2681338B1 (en) 2015-11-25
KR20140015356A (ko) 2014-02-06
BR112013021892B1 (pt) 2021-01-05

Similar Documents

Publication Publication Date Title
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
PH12015501439A1 (en) Oral care products comprising zinc oxide and trimethylglycine
MX2013011091A (es) Contenedor higienico.
MY191734A (en) Antiseptic-tolerant lactic acid bacteria
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
GB201106743D0 (en) Novel compounds
GB2511993A (en) Prebiotic formulations and methods of use
PL2707010T3 (pl) Szczepy bakteryjne należące do rodzaju bifidobacterium do zastosowania w leczeniu hipercholesterolemii
MY162948A (en) Gel composition
PH12014502545A1 (en) Food product with filling with high amount of live lactic cultures
WO2015092548A3 (en) Paenibacillus strains and compositions thereof that inhibit microorganisms
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
WO2014033574A3 (en) Protein stabilized probiotics and personal care products
MX2010008280A (es) Composicion para estimular la actividad de celula asesina natural.
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
AU345216S (en) Canning jar tool
IN2014CN02038A (es)
MX2013012967A (es) Composicion de miel con l-alanil-l-glutamina.
MX2013009993A (es) Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso.
WO2012138477A3 (en) Probiotic bacterial strains and method of use to decrease mortality due to bacterial disease
UA79305U (en) Sauce "banana-and-berry"
TH148303B (th) เซลล์ B. texasporus ที่บกพร่องในการเกิดสปอร์ และวิธีที่มีประสิทธิภาพและคุ้มทุน สำหรับการทำให้หมดฤทธิ์และการใช้งานของมัน
Mouradian Gingival recession and grafting
RU2011104901A (ru) Способ использования лечебных свойств "гриба" medusomuces gistvii в приготовлении экстрактов лекарственных растений

Legal Events

Date Code Title Description
FG Grant or registration